2019
DOI: 10.1016/j.ijpharm.2018.12.073
|View full text |Cite
|
Sign up to set email alerts
|

Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…107 The same anhydride was successfully used to link curcumin to pluronic F68 micelles. 108 It was also used to link doxorubicin to target alpha-fetoprotein receptor 109 and to chitosan nanoparticles, 110 as well as to PEI nanoparticles for the codelivery of siRNA, 111 or even for the formation of multilayer films with oxidized alginate as a nonvascular stent coating to ensure bactericidal and long-term release properties. 112 A magnetic version of chitosan nanoparticles was also studied.…”
Section: -Cis-aconitic Anhydridementioning
confidence: 99%
“…107 The same anhydride was successfully used to link curcumin to pluronic F68 micelles. 108 It was also used to link doxorubicin to target alpha-fetoprotein receptor 109 and to chitosan nanoparticles, 110 as well as to PEI nanoparticles for the codelivery of siRNA, 111 or even for the formation of multilayer films with oxidized alginate as a nonvascular stent coating to ensure bactericidal and long-term release properties. 112 A magnetic version of chitosan nanoparticles was also studied.…”
Section: -Cis-aconitic Anhydridementioning
confidence: 99%
“…Unfortunately, passive targeting via enhanced permeability and retention effect (EPR) is often insufficient, so researchers additionally apply various targeting ligands to ensure a sufficient accumulation and antitumor effect, such as antibodies, growth factors, transferrin, alpha-fetoprotein, cytokines, folic acid, low-density lipoprotein, tumor proteases, and tumor matrix proteins [ 16 , 17 , 18 , 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…AFP is known to selectively bind and to be internalized by a wide range of cancer cells. Different researchers reported its suitability for anticancer drug delivery systems as targeting motif [18][19][20][21]. Recent studies showed that endogenous full-length AFP may promote hepatic cancer progression and is not recommended for human treatment; however, the mechanism is not completely understood [22,23].…”
Section: Introductionmentioning
confidence: 99%